Obiettivo
The More Medicines for Tuberculosis (MM4TB) consortium evolved from the highly successful FP6 project, New Medicines for TB (NM4TB), that delivered a candidate drug for clinical development two years ahead of schedule. Building on these firm foundations and exploiting its proprietary pharmacophores, MM4TB will continue to develop new drugs for TB treatment. An integrated approach will be implemented by a multidisciplinary team that combines some of Europe's leading academic TB researchers with two major pharmaceutical companies and four SMEs, all strongly committed to the discovery of anti-infective agents. MM4TB will use a tripartite screening strategy to discover new hits in libraries of natural products and synthetic compounds, while concentrating on both classical and innovative targets that have been pharmacologically validated. Whole cell screens will be conducted against Mycobacterium tuberculosis using in vitro and ex vivo models for active growth, latency and intracellular infection. Hits that are positive in two or more of these models will then be used for target identification using functional genomics technologies including whole genome sequencing and genetic complementation of resistant mutants, yeast three hybrid, click chemistry and proteomics. Targets thus selected will enter assay development, structure determination, fragment-based and rational drug design programs; functionally related targets will be found using metabolic pathway reconstruction. Innovative techniques, based on microfluidics and array platforms, will be used for hit ranking, determining rates of cidality and confirming mechanism of action. Medicinal chemistry will convert leads to molecules with drug-like properties for evaluation of efficacy in different animal models and late preclinical testing.
Campo scientifico
- natural sciencesphysical sciencesclassical mechanicsfluid mechanicsmicrofluidics
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteinsproteomics
- medical and health sciencesbasic medicinemedicinal chemistry
- medical and health sciencesclinical medicinepneumologytuberculosis
- natural sciencesbiological sciencesgeneticsgenomes
Invito a presentare proposte
FP7-HEALTH-2010-single-stage
Vedi altri progetti per questo bando
Meccanismo di finanziamento
CP-IP - Large-scale integrating projectCoordinatore
1015 Lausanne
Svizzera
Mostra sulla mappa
Partecipanti (26)
Partecipazione conclusa
560024 BANGALORE
Mostra sulla mappa
751 05 Uppsala
Mostra sulla mappa
27100 Pavia
Mostra sulla mappa
CB2 1TN Cambridge
Mostra sulla mappa
Partecipazione conclusa
E1 4NS London
Mostra sulla mappa
75724 Paris
Mostra sulla mappa
119071 MOSCOW
Mostra sulla mappa
35122 Padova
Mostra sulla mappa
814 99 Bratislava
Mostra sulla mappa
8200 VESZPREM
Mostra sulla mappa
NR4 7UH Norwich
Mostra sulla mappa
560012 Bangalore
Mostra sulla mappa
560066 BANGALORE
Mostra sulla mappa
13100 Vercelli
Mostra sulla mappa
94010 BURLINGAME CA
Mostra sulla mappa
48940 Leioa
Mostra sulla mappa
41126 Modena
Mostra sulla mappa
50009 Zaragoza
Mostra sulla mappa
8092 Zuerich
Mostra sulla mappa
07749 JENA
Mostra sulla mappa
94250 GENTILLY
Mostra sulla mappa
7701 Rondebosch
Mostra sulla mappa
Partecipazione conclusa
1025 Saint Sulpice
Mostra sulla mappa
75654 Paris
Mostra sulla mappa
1015 Lausanne
Mostra sulla mappa
65929 Frankfurt Am Main
Mostra sulla mappa